The clinical studies STEP-4 (semaglutide), SURMOUNT-4 and the 3-year extension of SURMOUNT-1 (tirzepatide), showed that as long as GBT is maintained, weight loss is likely to be maintained, whereas patients who discontinued the GBT treatment regained around two-thirds of their weight loss within one year [16,[147], [148], [149]]
Grateful to my patients and my team who made this possible
Invigor Medical does not supply FDA-approved branded medications
Side effects were not worse in a major way in that small study, but that does not mean it is right for everyone
InnoSlim specifically targets metabolic activation, while Grains of Paradise enhances thermogenesis, gently increasing the body's calorie-burning capacity
Strandwitz P (2018) Neurotransmitter modulation by the gut microbiota